AUBAGIO

Identification of Aubagio

No description

Google image searchProduct monograph

Active ingredient

teriflunomide, 14 MG

DIN: 02416328

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: SANOFI-AVENTIS CANADA INC

Date: 17-APR-2024

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AK — Dihydroorotate dehydrogenase (DHODH) inhibitors (ATC, ATC/DDD)
• L04AK02 — TERIFLUNOMIDE (ATC/DDD)

Reference brand drug: Aubagio

External Links for Aubagio

Search on Google

• Aubagio side effects
• Aubagio dosage
• teriflunomide side effects
• teriflunomide dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find aubagio photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.